Share Article
Urenco’s TMF Project marks 2 million safe working hours with donation to local charities
10 November 2016 Urenco ChemPlants NewsOn 19 October, Urenco and its project partners achieved 2million safe working hours on the construction of its Tails Management Facility (TMF) at Urenco Capenhurst.
To mark this safe working milestone, Urenco and its project partners - Jacobs, Balfour Beatty, Kier, Laker Vent Engineering, Rainham Industrial Services and M&W Hargreaves - are donating £15,000 to three local charities.
The chosen charities are Claire House Children’s Hospice, Zoe’s Place and Medcare.
Commenting on the donation, Pleun E. Schuddebeurs, Managing Director, Urenco ChemPlants said:
“Safety is always Urenco's core priority and we are proud to have achieved this significant milestone of two million safe working hours on our Tails Management Facility project. To recognise this achievement, our employees have chosen to donate to three charities, who continue to make a difference in our local community.”
Share Article
About Urenco
Urenco is an international supplier of uranium enrichment services, fuel cycle products and related solutions with sustainability at the core of our business. Operating in a pivotal area of the nuclear fuel supply chain for over 50 years, Urenco understands the importance of energy security and facilitates the reliable delivery of low carbon electricity generation for consumers around the world.
With its head office in London, UK, Urenco’s global presence ensures diversity and security of supply for customers through enrichment facilities in Germany, the Netherlands, the UK and the USA. Through our technology and the expertise of our people, the Urenco Group provides safe, cost effective and reliable services, operating within a framework of high environmental, social and governance standards, complementing international safeguards.
Urenco is making a positive contribution to global climate change goals through our core business and we are committed to achieving net zero carbon emissions by 2040.
We are committed to continued investment in the responsible management of nuclear materials; innovation activities with clear sustainability benefits, such as nuclear medicine, industrial efficiency and research; and nurturing the next generation of scientists and engineers.
Media enquiries